力大圖書

Andrews' Diseases of the Skin: Clinical Dermatology 13/E(IE國際版,無電子書) 2020
-皮膚科(醫學美容)
- 編號： -0323547540
- 作者：William D. James MD
- 原價-5300 - (熱賣價)4500 - 節省 ↓15%
- 加入購物車提交
推薦指數：
- 內容介紹
Andrews' Diseases of the Skin: Clinical Dermatology 13th Edition(IE國際版,無電子書)
by William D. James MD (Author), Dirk Elston MD (Author), James R. Treat MD (Author), Misha A. Rosenbach MD (Author), Isaac Neuhaus MD (Author)
Paperback
Publisher: Elsevier
ISBN-10: 0323547540
ISBN-13: 978-0323547543
2020

Now in a fully revised thirteenth edition, Andrews' Diseases of the Skin remains your single-volume, must-have resource for core information in dermatology. From residency through clinical practice, this award-winning title ensures that you stay up to date with new tools and strategies for diagnosis and treatment, new entities and newly recognized diseases, and current uses for tried-and-true and newer medications. It's the reference you'll turn to again and again when faced with a clinical conundrum or therapeutically challenging skin disease.

Key Features
Utilizes a concise, clinically focused, user-friendly format that clearly covers the full range of common and rare skin diseases.
Provides access to approximately 20 videos online, depicting chemical peels, Q-switched laser tattoo removal, ED&C (electrodesiccation and curettage), nerve block, and more.
Provides outstanding visual support with 1,340 illustrations - more than 500 new to this edition.
Presents comprehensively updated information throughout, including new and unusual clinical presentations of syphilis, new diagnostic classifications and therapies for vascular anomalies, and an updated pediatric and genodermatosis review.
Covers new and evolving treatments for inflammatory, neoplastic, and blistering skin diseases among others.　 New biologics and phosphodiesterase inhibitors for psoriasis and atopic dermatitis, JAK inhibitors for alopecia areata and vitiligo, immune checkpoint inhibitors for melanoma and rituximab for pemphigus are all covered.
Features a revised and revamped cutaneous adverse drug reaction section, including novel eruptions from new and emerging chemotherapeutic agents and small molecule/targeted inhibitors.
Discusses new and emerging viruses including Zika and human polyomaviruses.

└ 返回上一頁